A relatively higher average level of MALAT1 expression (12.31 ± 1.34 vs. 11.49 ± 1.43, p < 0.001) was detected in the CRC tissues exhibiting higher (i.e., >median vs. ≤median) TCF12 mRNA expression levels (Table 1), suggesting that TCF12 not only formed a complex with MALAT1 but that also its gene expression was coordinated with that of MALAT1 in CRC patients. This evidence concerns the gene TCF12 and colorectal carcinoma.